UK audit body finds no-deal Brexit drug supply preparation lacking

Despite the governments "multi-layered strategy" for mitigating risk, the Royal Pharmaceutical Society voiced concern about drug shortages in the no-deal Brexit. In a study on the status of the medicinal supply after a no-deal Brexit, the UK National Audit Office (NAO) has found that "important amounts" of the job still need to be carried out The documents compiled by the Cabinet Office this month under the codename of Operation Yellowhammer, ....